ACELLULAR SOFT TISSUE-DERIVED MATRICES AND METHODS FOR PREPARING SAME
A composition including delipidated, decellularized adipose tissue and delipidated, decellularized fascial tissue is provided. The composition may further include exogenous tissuegenic cells, an exogenous growth-inductive substance, and/or a carrier. The composition is suitable for implantation into a living body in plastic surgery procedures, including reconstructive or cosmetic surgery procedures, wound care procedures or other procedures of regenerative medicine. A method of preparing an acellular soft tissue-derived matrix from adipose tissue and fascial tissue is also provided. The method involves preparing a delipidated, decellularized adipose-derived matrix by delipidizing the adipose tissue and decellularizing the adipose tissue; preparing a delipidated, decellularized fascia-derived matrix by delipidizing the fascial tissue and decellularizing the fascial tissue; and combining the delipidated, decellularized adipose-derived matrix and the delipidated, decellularized fascia-derived matrix to produce said acellular soft tissue-derived matrix. The resulting Acellular soft tissue-derived matrix may be partially dried, substantially dried, or not dried.
1 . A composition, comprising delipidated, decellularized adipose tissue and delipidated, decellularized fascial tissue.
2 . The composition of claim 1 , wherein said delipidated, decellularized adipose tissue is substantially free of native nucleic acids, or said delipidated, decellularized fascial tissue is substantially free of native nucleic acids, or both.
3 . The composition of claim 1 , further comprising exogenous tissuegenic cells.
4 . The composition of claim 1 , further comprising at least one exogenous growth-inductive substance.
5 . The composition of claim 1 , further comprising a carrier.
6 . The composition of claim 5 , wherein said carrier comprises a substance selected from the group consisting of an isotonic solution, a sodium chloride solution, a lactated Ringer's solution, a phosphate-buffered saline solution, platelet rich plasma, hyaluronic acid, a derivative of hyaluronic acid, sodium hyaluronate, thrombin, fibrin, glycerin, collagen, lecithin, sugars, polysaccharides, and solutions thereof.
7 . An implant comprising the composition of claim 1 .
8 . A method of preparing an acellular soft tissue-derived matrix from adipose tissue and fascial tissue, said method comprising the steps of:
delipidizing said adipose tissue;
decellularizing said adipose tissue;
delipidating said fascial tissue;
decellularizing said fascial tissue; and
combining said adipose tissue and said fasical tissue before, after, or during any of said delipidizing and decellurizing steps to produce said acellular soft tissue-derived matrix.
9 . The method of claim 8 , wherein said delipidating said adipose tissue is performed with a polar organic solvent
10 . The method of claim 8 , wherein said delipidating said fascial tissue is performed with a polar organic solvent.
11 . The method of claim 8 , wherein said decellularizing said adipose tissue is performed with a detergent solution.
12 . The method of claim 8 , wherein said decellularizing said fascial tissue is performed with a detergent solution.
13 . The method of claim 8 , further comprising the step of subjecting said adipose tissue, or said fascial tissue, or both, to a size reduction step.
14 . The method of claim 8 , further comprising partially drying said acellular soft tissue-derived matrix to produce a pre-hydrated acellular soft tissue-derived matrix.
15 . The method of claim 8 , wherein said acellular soft tissue-derived matrix has not been subjected to drying whereby a pre-hydrated acellular soft tissue-derived matrix is produced.
16 . The method of claim 8 , wherein said acellular soft tissue-derived matrix is substantially dried to a water content of no more than about 35% by weight, based on the total weight of said acellular soft tissue-derived matrix, to produce a dried acellular soft tissue-derived matrix.
17 . The method of claim 16 , further comprising subjecting said dried acellular soft tissue-derived matrix to a size reduction step to produce a particulate acellular soft tissue-derived matrix.
18 . The method of claim 8 , further comprising the step of disinfecting said adipose tissue.
19 . The method of claim 8 , further comprising the step of disinfecting said fascial tissue.
20 . The method of claim 8 , further comprising contacting said acellular soft tissue-derived matrix with a preservative.
21 . A composition comprising delipidated, decellularized fascial tissue.
22 . A method of preparing an acellular fascia-derived matrix from fascial tissue comprising the separate steps of:
delipidating said fascial tissue; and
decellularizing said fascial tissue.